The USPTO recently announced a new COVID-19 prioritized examination program for certain trademark and service mark applications…
The U.S. Patent and Trademark Office (USPTO) recently announced a new COVID-19 prioritized examination program for certain trademark and service mark applications. It is available for products that are subject to U.S. Food and Drug Administration (FDA) approval for use in the prevention and/or treatment of COVID-19 and for medical or medical research service for the prevention and/or treatment of COVID-19.
“Inventors and entrepreneurs are working around the clock to develop products that will help prevent, diagnose, treat, or cure COVID-19,” Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director of the USPTO said in a press statement. “Accelerating initial examination of COVID-19-related trademark applications for these products, as well as service mark applications for medical and medical research services, will help to bring important and possibly life-saving treatments to market more quickly.”
Eligibility for this Prioritized Examination Program
Typically, the USPTO examines trademark applications in the order that they are received. However, there are procedures where an applicant may request that the initial application be advanced out of turn when special circumstances exist. Under 37 C.F.R. § 2.146(a)(3), an applicant may file a petition to the Director of the USPTO to have the Director exercise supervisory authority to advance the initial application out of its regular order.
In response to the COVID-19 outbreak, the USPTO will accept petitions to advance the initial examination of applications for marks used to identify qualifying COVID-19 medical products and services. Additionally, the agency will waive the fee for such petitions.
As set forth in the USPTO Notice, to qualify for fast-track examination, goods and services must consist of: (i) “pharmaceutical products or medical devices such as diagnostic tests, ventilators, and personal protective equipment, including surgical masks, face shields, gowns, and gloves, that prevent, diagnose, treat or cure COVID-19 and are subject to approval by the United States Food and Drug Administration”; or (ii) “medical services or medical research for the prevention, diagnosis, treatment of, or cure for COVID-19.”
The FDA approvals for the pharmaceutical products or medical devices may include an Investigational New Drug application, an Investigational Device Exemption, a New Drug Application, a Biologics License Application, a Premarket Approval, or an Emergency Use Authorization.
How to Take Advantage of Accelerated Trademark Examination
Our attorneys can assist trademark applicants with this process. To seek expedited examination, applicants must first file a trademark application. The next step is to file a petition to the Director that includes the newly assigned application serial number. The application and petition must be filed through the Trademark Electronic Application System (TEAS). The petition must include a statement of facts with a supporting affidavit or declaration pursuant to 37 C.F.R. § 2.20. This statement must detail the applicant’s COVID-19 medical goods or services associated with the subject mark and also explain why the goods or services qualify for prioritized examination.
The USPTO began accepting petitions for fast-track examination on June 16, 2020. According to the USPTO, it plans to monitor the workload and resources needed to administer the program, and the effectiveness of the program. If the USPTO determines that modifications are needed or decides that it will no longer grant petitions for prioritized examination, it will notify the public before taking action.
If you have questions, please contact us
If you have any questions or if you would like to discuss the matter further, please contact the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.
What Business Owners Get Wrong Before Meeting a Litigation Attorney
What should you expect when meeting a litigation attorney about a business dispute? You should expect to describe the dispute in your own words, hand over the most important documents, flag any deadlines or immediate threats, and leave with a clearer picture of the problem, what information is still needed, and the likely next steps. […]
Arbitration vs. Litigation vs. Mediation: What New Jersey Businesses Should Know Before Signing a Contract
Arbitration resolves disputes privately before an arbitrator whose decision is usually final, while litigation resolves them in court with full rights of appeal. Whether a business ends up in arbitration or litigation is often decided when it signs the contract, long before any dispute arises. Key Takeaways When facing a contract dispute, carefully consider your […]
Can You Own Part of a New Jersey Business Without a Written Agreement?
Can you own part of a business in New Jersey without a written agreement? Yes, it is possible. Under New Jersey’s Uniform Partnership Act, a partnership can arise when two or more people carry on a business as co-owners for profit, whether or not they ever intended to form one. Ownership doesn’t necessarily depend on […]
Crisis-Proofing Your New Jersey Business: Building a Crisis Response Plan Before You Need One
For New Jersey businesses, crisis preparedness should be viewed as a legal and operational function, not simply an emergency-management exercise. A well-designed crisis response plan can help preserve evidence, protect confidential communications, meet reporting obligations, limit unnecessary exposure, and prevent an already difficult situation from becoming a larger legal problem. Key Takeaways A serious crisis […]
Monmouth County's Next Development Wave: What Developers and Investors Need to Know
Monmouth County is entering a significant new phase of development. For those looking to acquire property or undertake a new project, understanding the market opportunity is only the beginning. The more important question is whether a particular property can actually be developed as contemplated and what approvals, agreements, and other conditions will be required to […]
Are Your Conversations with AI Shielded from Discovery? Courts Are Split
Whether a client’s prompts to a generative AI tool and the documents it produces are protected from disclosure depends on the case type, who claims protection, and whether counsel was involved. In United States v. Heppner, a New York federal judge ruled that a criminal defendant’s communications with an AI platform were protected by neither […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
